M&A Deal Summary

IVERIC bio Acquires Inception 4

On October 31, 2018, IVERIC bio acquired life science company Inception 4

Acquisition Highlights
  • This is IVERIC bio’s 1st transaction in the Life Science sector.
  • This is IVERIC bio’s 1st transaction in the United States.
  • This is IVERIC bio’s 1st transaction in California.

M&A Deal Summary
Date 2018-10-31
Target Inception 4
Sector Life Science
Buyer(s) IVERIC bio
Deal Type Add-on Acquisition

Target

Inception 4

San Diego, California, United States
Inception 4, Inc. is a biopharmaceutical company. Inception 4, Inc. was founded in 2013 and is based in San Diego, California.

Search 202,137 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

IVERIC bio

Cranbury, New Jersey, United States
Category Company
Founded 2007
Sector Life Science
Revenue 210M USD (2017)
DESCRIPTION

IVERIC bio is a biopharmaceutical company specializing in the development of novel therapeutics to treat ophthalmic diseases, with a focus on orphan and age-related retinal diseases. IVERIC bio was founded in 2007 and is based in Cranbury, New Jersey.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (California) 1 of 1
Country (United States) 1 of 1
Year (2018) 1 of 1
Mergr

Product

Company

Legal